Sermorelin peptide therapy involves regular injections to increase growth hormone levels, which can have various advantages for losing weight and improving body composition
Reconstituted peptide solutions must be refrigerated at 28 C, protected from light, and never frozen to prevent aggregation and loss of biological activity
Large-scale trials of semaglutide and tirzepatide have demonstrated sustained weight reductions approaching 1522% of baseline body weight in adults with overweight and obesity [1][2][3]
Huang T, Gu J, Zhang K, Sun L, Xue X, Zhang C, et al
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Ozempic, Weygovy